VR

Vanajakshi Raju Guntumadugu

Active Director Director DIN 09695307
DIN 09695307 First appointment Aug 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vanajakshi Raju Guntumadugu

Data last updated:

Vanajakshi Raju Guntumadugu is a Director at Abcon Pharma Private Limited (since 2022). The company operates in Food And Beverages.

DIN 09695307
Primary Designation Director
Industry Food And Beverages
First Appointment 23 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abcon Pharma Private Limited U24304MH2022PTC389044
Director23 Aug 20222022Active

Board colleagues of Vanajakshi Raju Guntumadugu

NameDINCompanyDesignation
Manikanta Peethani08610334Abcon Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Abcon Pharma Private Limited
Premium access

Shareholding and investment profile for Vanajakshi Raju Guntumadugu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanajakshi Raju Guntumadugu

Vanajakshi Raju Guntumadugu currently holds 1 directorship: Abcon Pharma Private Limited (Director, since 23 Aug 2022).

Vanajakshi Raju Guntumadugu was first appointed on 23 Aug 2022 as Director at Abcon Pharma Private Limited.

The current boards of Vanajakshi Raju Guntumadugu's companies include Manikanta Peethani (Abcon Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available